CHST4 and cholangiocarcinoma: In conclusion, this study explored the potential therapeutic targets of CCA through bioinformatics techniques and the construction of cholangiocarcinoma models, and the discovered prognostic gene (CHST4) may be used for research and development of new clinical drugs to alleviate the urgent situation of low survival rate in CCA patients.